Showing results (61-70 of 73) with videos related to

Sort By:
Pageof 8
Rheumatology (Oxford, England)|February 22, 2023
CanVasc consensus recommendations for the use of avacopan in antineutrophil cytoplasm antibody-associated vasculitis: 2022 addendumDavid Turgeon, Volodko Bakowsky, Corisande Baldwin, et al.
Health Technology Assessment (Winchester, England)|September 26, 2022
Plasma exchange and glucocorticoids to delay death or end-stage renal disease in anti-neutrophil cytoplasm antibody-associated vasculitis: PEXIVAS non-inferiority factorial RCTDavid Jayne, Michael Walsh, Peter A Merkel, et al.
Clinical Ophthalmology (Auckland, N.Z.)|March 14, 2019
Neural network and logistic regression diagnostic prediction models for giant cell arteritis: development and validationEdsel B Ing, Neil R Miller, Angeline Nguyen, et al.
Arthritis and Rheumatism|June 7, 2013
Association of granulomatosis with polyangiitis (Wegener's) with HLA-DPB1*04 and SEMA6A gene variants: evidence from genome-wide analysisGang Xie, Delnaz Roshandel, Richard Sherva, et al.
The New England Journal of Medicine|February 14, 2020
Plasma Exchange and Glucocorticoids in Severe ANCA-Associated VasculitisMichael Walsh, Peter A Merkel, Chen-Au Peh, et al.
The Journal of Rheumatology|September 16, 2020
CanVasc Consensus Recommendations for the Management of Antineutrophil Cytoplasm Antibody-associated Vasculitis: 2020 UpdateArielle Mendel, Daniel Ennis, Ellen Go, et al.
Annals of the Rheumatic Diseases|March 23, 2023
Rituximab versus azathioprine for maintenance of remission for patients with ANCA-associated vasculitis and relapsing disease: an international randomised controlled trialRona M Smith, Rachel B Jones, Ulrich Specks, et al.
Annals of the Rheumatic Diseases|June 26, 2020
Rituximab as therapy to induce remission after relapse in ANCA-associated vasculitisRona M Smith, Rachel Bronwen Jones, Ulrich Specks, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 29, 2016
Identification of Functional and Expression Polymorphisms Associated With Risk for Antineutrophil Cytoplasmic Autoantibody-Associated VasculitisPeter A Merkel, Gang Xie, Paul A Monach, et al.
Annals of the Rheumatic Diseases|July 3, 2026
Genetic biomarkers of clinical manifestations in giant cell arteritis define distinct patient subgroupsGonzalo Borrego-Yaniz, Vera Fuentes-Moreno, Lourdes Ortiz-Fernández, et al.
Pageof 8